BioMarin Pharmaceutical Statistics

Total Valuation

LON:0HNC has a market cap or net worth of GBP 8.25 billion. The enterprise value is 7.76 billion.

Market Cap	8.25B
Enterprise Value	7.76B

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	191.78M
Shares Outstanding	n/a
Shares Change (YoY)	+1.65%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	179.36M

Valuation Ratios

The trailing PE ratio is 20.36 and the forward PE ratio is 12.77.

PE Ratio	20.36
Forward PE	12.77
PS Ratio	3.61
PB Ratio	1.84
P/TBV Ratio	1.99
P/FCF Ratio	17.09
P/OCF Ratio	15.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.76, with an EV/FCF ratio of 16.06.

EV / Earnings	19.13
EV / Sales	3.55
EV / EBITDA	12.76
EV / EBIT	14.64
EV / FCF	16.06

Financial Position

The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.10.

Current Ratio	5.52
Quick Ratio	3.20
Debt / Equity	0.10
Debt / EBITDA	0.73
Debt / FCF	0.96
Interest Coverage	59.71

Financial Efficiency

Return on equity (ROE) is 9.64% and return on invested capital (ROIC) is 7.12%.

Return on Equity (ROE)	9.64%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	7.12%
Return on Capital Employed (ROCE)	10.98%
Revenue Per Employee	751,134
Profits Per Employee	133,382
Employee Count	3,040
Asset Turnover	0.42
Inventory Turnover	0.46

Taxes

In the past 12 months, LON:0HNC has paid 116.43 million in taxes.

Income Tax	116.43M
Effective Tax Rate	22.31%

Stock Price Statistics

The stock price has decreased by -27.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-27.47%
50-Day Moving Average	57.98
200-Day Moving Average	64.40
Relative Strength Index (RSI)	53.65
Average Volume (20 Days)	722

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.12

Income Statement

In the last 12 months, LON:0HNC had revenue of GBP 2.28 billion and earned 405.48 million in profits. Earnings per share was 2.09.

Revenue	2.28B
Gross Profit	1.85B
Operating Income	553.77M
Pretax Income	521.91M
Net Income	405.48M
EBITDA	624.31M
EBIT	553.77M
Earnings Per Share (EPS)	2.09

Full Income Statement

Balance Sheet

The company has 984.77 million in cash and 465.91 million in debt, giving a net cash position of 518.86 million.

Cash & Cash Equivalents	984.77M
Total Debt	465.91M
Net Cash	518.86M
Net Cash Per Share	n/a
Equity (Book Value)	4.48B
Book Value Per Share	23.38
Working Capital	2.20B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 542.00 million and capital expenditures -58.89 million, giving a free cash flow of 483.11 million.

Operating Cash Flow	542.00M
Capital Expenditures	-58.89M
Free Cash Flow	483.11M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.01%, with operating and profit margins of 24.25% and 17.76%.

Gross Margin	81.01%
Operating Margin	24.25%
Pretax Margin	22.86%
Profit Margin	17.76%
EBITDA Margin	27.34%
EBIT Margin	24.25%
FCF Margin	21.16%

Dividends & Yields

LON:0HNC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.65%
Shareholder Yield	n/a
Earnings Yield	4.91%
FCF Yield	5.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HNC has an Altman Z-Score of 7.57 and a Piotroski F-Score of 7.

Altman Z-Score	7.57
Piotroski F-Score	7